pharma · Hyperphagia · Bariatric Surgery · AARD
Ark Therapeutics
Ark Therapeutics clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Boulder, USA
- Founded
- 2025
- Employees
- 4
- Programs
- 6
- Drugs
- 5
- Patents
- 7
Ark Therapeutics projects
6 ClinicalTrials.gov programs sponsored by Ark Therapeutics.
Ark Therapeutics has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ARD-101
Ark Therapeutics
Hyperphagia
1 trial -
Placebo
Ark Therapeutics
Hyperphagia
1 trial -
ARD-101
Ark Therapeutics
Bariatric Surgery
1 trial -
ARD-101
Ark Therapeutics
Obesity
1 trial -
ARD-101
Ark Therapeutics
Prader-Willi Syndrome
1 trial -
Low Dose ARD-501
Ark Therapeutics
Autism Spectrum Disorder
1 trial
Frequently asked questions
How many clinical projects does Ark Therapeutics have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.